Overview

Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children.

Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long term tolerability of Fesoterodine and its efficacy for overactive bladder syndrome in children.
Phase:
Phase 3
Details
Lead Sponsor:
Stéphane Bolduc
Collaborator:
Pfizer
Treatments:
Fesoterodine